You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
|
|---|---|
| Published in |
Arthritis Research & Therapy, September 2008
|
| DOI | 10.1186/ar2506 |
| Pubmed ID | |
| Authors |
Richard Furie, William Stohl, Ellen M Ginzler, Michael Becker, Nilamadhab Mishra, Winn Chatham, Joan T Merrill, Arthur Weinstein, W Joseph McCune, John Zhong, Wendy Cai, William Freimuth, the Belimumab Study Group |
Mendeley readers
The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Italy | 1 | <1% |
| United Kingdom | 1 | <1% |
| Austria | 1 | <1% |
| Spain | 1 | <1% |
| Singapore | 1 | <1% |
| Unknown | 128 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 21% |
| Student > Ph. D. Student | 15 | 11% |
| Student > Bachelor | 13 | 10% |
| Other | 11 | 8% |
| Student > Postgraduate | 11 | 8% |
| Other | 29 | 21% |
| Unknown | 29 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 38% |
| Agricultural and Biological Sciences | 20 | 15% |
| Immunology and Microbiology | 5 | 4% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Other | 17 | 13% |
| Unknown | 33 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2014.
All research outputs
#4,835,823
of 25,374,647 outputs
Outputs from Arthritis Research & Therapy
#1,028
of 3,381 outputs
Outputs of similar age
#17,442
of 98,572 outputs
Outputs of similar age from Arthritis Research & Therapy
#14
of 47 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,572 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.